entertainment -WSS

entertainment

author：focus 2025-09-30 01:12:29 - browse：5

Zachary Kirimi inside a pharmacy -- health policy coverage from STAT — Zachariah Kirimi is a pharmacist who uses the Maisha Meds app to help manage his inventory and offer subsidized products to patients. Courtesy Jack Hewson/Maisha Meds

WASHINGTON — For an app that helps pharmacies in Africa manage their medicines, the term “pharmacy benefit manager” has become a dirty word.

The organization, called Maisha Meds, plays the role of a middleman between international groups like USAID and the Gates Foundation and pharmacies. By definition, it’s a PBM. But since it’s a nonprofit company and it subsidizes medicines and tests aimed at promoting public health, it’s hesitant to describe itself that way.

“Because so many people kind of think of PBMs in the U.S. as the enemy, we don’t ourselves use that term,” said Maisha Meds’ founder and CEO, Jessica Vernon.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： A disappointing year of Humira biosimilars

hotspot

explore

WSS

Tome Biosciences co

To avoid data mishandling cases, universities eye AI and other tools

Medicare threatens to cut off funding for HCA's Mission hospital

Key House Republican on health care plans exit from Congress

Doctors on social media are being harassed and cyberbullied

Juul documents reveal insider tactics on political lobbying

leisure time

entertainment

knowledge

What does generative AI mean for health care? We asked experts

Medicare threatens to cut off funding for HCA's Mission hospital

Medical leaders decry Supreme Court decision on affirmative action

Bernie Sanders gets little from pharma CEOs on drug prices

Duchenne breakthrough therapy leaves behind pioneering families

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Medical records are filled with copy

Why Eli Lilly’s earnings didn’t quite live up to the hype

How to save PrEP access — and even expand it

What should King Charles tell the public about his cancer?

hotspot

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Juul documents reveal insider tactics on political lobbying

Senators start work on Medicare physician payment reform

Readout Newsletter: Amylyx, Aurinia, and IQVIA

ACIP vaccine advisory panel sees its vacancies filled

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

focus

hotspot

explore

hotspot